ISTA PHARMACEUTICAL (NASDAQ:ISTA)
3.76
-0 (-0%)
| ISTA PHARMACEUTICAL (NASDAQ:ISTA) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $6.83 | ||
| Open | $3.77 | 52 Week Low | $1.01 | ||
| Day High | $3.89 | P/E | N/A | ||
| Day Low | $3.69 | EPS | $-1.78 | ||
| Volume | 302,772 | ||||
| More ISTA Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| MYGN | 3 | VVUS | 3 |
| BGFV | 2 | PACR | 2 |
| MXWL | 2 | ANH | 2 |
| BIO | 2 | DVA | 2 |
| HIG | 2 | NETL | 2 |
| QLTY | 2 | CLRT | 2 |
Entities who have mentioned ISTA
- Lazard | View Related Stories »
- UBS | View Related Stories »
- Wachovia | View Related Stories »
- Barington Capital Group | View Related Stories »
- Scopia Capital | View Related Stories »
- Jefferies & Co | View Related Stories »
- After-Hours Movers | View Related Stories »
- Stock Buyback | View Related Stories »
- 13G | View Related Stories »
- Southeastern Asset Management | View Related Stories »
- Clinton Group | View Related Stories »
- Roth Capital | View Related Stories »
- ThinkPanmure | View Related Stories »
- Deerfield Management | View Related Stories »
- Piper Jaffray | View Related Stories »
- Citi | View Related Stories »
- Barclays | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Factory Orders | View Related Stories »
- Trading Radar | View Related Stories »
View All Major News StreetInsider.com Major News for ISTA
- Ista Pharma (ISTA) Offers FY10 Outlook
- ISTA Pharma (ISTA) Reports Preliminary FY09 Revs of $110.6M vs. $108.6M Consensus
- ISTA Pharmaceuticals (ISTA) Tops Q3 EPS by 3c; Guides In-line for FY Revenues
View All ReportsStreetInsider.com Reports on ISTA
- Ista Pharma (ISTA) Offers FY10 Outlook
- ISTA Pharma (ISTA) Reports Preliminary FY09 Revs of $110.6M vs. $108.6M Consensus
- ISTA Pharma (ISTA) Submits Bromfenac Ophthalmic NDA to U.S. FDA
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
- ISTA Pharmaceuticals (ISTA) Tops Q3 EPS by 3c; Guides In-line for FY Revenues
View All Press ReleasesCompany Press Releases on ISTA
- ISTA Pharmaceuticals Announces 2010 Financial Guidance
- ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
- ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once-Daily XiDay(TM)
StreetInsider Reports on ISTA by Category
View All BlogsBlogs on ISTA
- The Top 25
- Healthcare Takeover Talk Continues
- Stocks to Watch This Week
- Closing Update for Wednesday, Sept. 9
- ISTA’s Eye Drug Shows Success
View All FilingsSEC Filings on ISTA
- Form 8-K ISTA PHARMACEUTICALS For: Feb 09
- Form 8-K ISTA PHARMACEUTICALS For: Feb 01
- Form 4 ISTA PHARMACEUTICALS For: Feb 03 Filed by: MCMULLIN KIRK
- Form 4 ISTA PHARMACEUTICALS For: Feb 03 Filed by: MCGINLEY KATHLEEN
- Form 4 ISTA PHARMACEUTICALS For: Feb 03 Filed by: SILVERNAIL LAUREN P
Comments on recent ISTA articles
Comments on ISTA
No comments are currently available.
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
on Aug 5, 2009
at 10:00 PM ISTA This company has wonderful products and will grow revenues painstakingly slowly. The REAL worth of ISTA is its share value to a corporate buyer. My cost basis is < $1 ... I'm holding for what I see as an inevitable buyout. I'm in the business/industry. Their products are unique and their competitors in BIG pharma can't catch up with comparable products for less than they can pay for ISTA. Bart
Article: ISTA Pharma (ISTA) Reports Q2 Results; Raises FY09 Sales Guidance